Home/Opna Bio/Reinaldo Diaz, MBA
RD

Reinaldo Diaz, MBA

Chief Executive Officer

Opna Bio

Therapeutic Areas

Opna Bio Pipeline

DrugIndicationPhase
Zavabresib (OPN-2853)MyelofibrosisPhase 1
OPN-6602Multiple MyelomaPhase 1
Multi-functional DegradersMyeloma and LymphomaPreclinical
OPN-FMRPSolid TumorsResearch